Other OTC - Delayed Quote USD

Comvita Limited (CVNZF)

1.5600 0.0000 (0.00%)
At close: March 14 at 10:04 AM EDT
Loading Chart for CVNZF
DELL
  • Previous Close 1.5600
  • Open 1.5600
  • Bid --
  • Ask --
  • Day's Range 1.5600 - 1.5600
  • 52 Week Range 1.5583 - 2.0900
  • Volume 3,000
  • Avg. Volume 47
  • Market Cap (intraday) 109.552M
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) 52.00
  • EPS (TTM) 0.0300
  • Earnings Date --
  • Forward Dividend & Yield 0.02 (1.50%)
  • Ex-Dividend Date Apr 3, 2024
  • 1y Target Est --

Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney, gourmet honey, and elixirs and lozenges, as well as oral care and kids health products. It also provides solutions for digestive health, skin health, heart and metabolic health, and immunity. In addition, the company engages in the apiary ownership and forest management. It offers its products through supermarkets, pharmacies, and healthcare stores, as well as online. Comvita Limited was incorporated in 1974 and is based in Te Puke, New Zealand.

www.comvita.co.nz

595

Full Time Employees

June 30

Fiscal Year Ends

Recent News: CVNZF

Performance Overview: CVNZF

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CVNZF
16.04%
S&P/NZX 50 INDEX GROSS ( GROSS
0.11%

1-Year Return

CVNZF
16.46%
S&P/NZX 50 INDEX GROSS ( GROSS
1.35%

3-Year Return

CVNZF
27.77%
S&P/NZX 50 INDEX GROSS ( GROSS
7.92%

5-Year Return

CVNZF
56.23%
S&P/NZX 50 INDEX GROSS ( GROSS
18.05%

Compare To: CVNZF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CVNZF

Valuation Measures

As of 4/18/2024
  • Market Cap

    173.74M

  • Enterprise Value

    236.59M

  • Trailing P/E

    51.03

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.83

  • Price/Book (mrq)

    0.79

  • Enterprise Value/Revenue

    1.05

  • Enterprise Value/EBITDA

    9.64

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.64%

  • Return on Assets (ttm)

    0.27%

  • Return on Equity (ttm)

    1.58%

  • Revenue (ttm)

    225.43M

  • Net Income Avi to Common (ttm)

    3.7M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.93M

  • Total Debt/Equity (mrq)

    50.72%

  • Levered Free Cash Flow (ttm)

    -13.66M

People Also Watch